SRRK is the ticker symbol for Scholar Rock Holding Corp, a publicly traded Healthcare sector company listed on Nasdaq. 13F Pro tracks SRRK with AI-powered analysis, a 32-signal quality score, SEC EDGAR financials, insider transactions, and institutional 13F holdings — all sourced directly from public SEC filings.

Is SRRK a good stock to buy?

SRRK is tracked on 13F Pro with SEC EDGAR data, but is not currently included in our 32-signal AI quality ranking. The full company profile with financials and AI insights is at https://13fpro.ai/company/SRRK.

Where does 13F Pro source SRRK data?

All Scholar Rock Holding Corp fundamentals and ownership data come directly from SEC EDGAR. Scholar Rock Holding Corp files with the SEC under CIK 1727196. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

Scholar Rock Holding Corp(SRRK)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2026-06-30.

Scholar Rock Holding Corp (SRRK) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. SRRK is not currently included in 13F Pro's AI-ranked quality universe — this company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. rankings refresh on jan 1, apr 1, jul 1, oct 1. Based on the latest XBRL financial filings (Q2 2026), Scholar Rock Holding Corp reports net income of $-109.9M, free cash flow of $-70.3M. Top institutional holders of SRRK by reported 13-F value include FMR, Siren, L.L.C., BlackRock, based on the most recent SEC filings. SRRK trades on the Nasdaq exchange and files with the SEC under CIK 1727196. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate SRRK daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Scholar Rock Holding Corp directly from SEC EDGAR.

Revenue

$0.00

Net Income

$-109.9M

Free Cash Flow

$-70.3M

SRRK key financials by period

Scholar Rock Holding Corp reported revenue, net income and margins by fiscal period, from SEC filings.
Period	Form	Revenue	Net income	Operating margin
FY 2022	10-K	$33.2M	$-134.5M	—
FY 2021	10-K	$18.8M	$-131.8M	—
FY 2020	10-K	$15.4M	$-86.5M	—
FY 2019	10-K	$20.5M	$-51.0M	—

Institutions holding SRRK

Institutional investors reporting a position in Scholar Rock Holding Corp on SEC Form 13F.
Institution	Shares	Value	Reported
FMR	17,995,241	$989.7M	2026-06-30
Siren, L.L.C.	9,575,013	$526.6M	2026-06-30
BlackRock	9,494,084	$522.2M	2026-06-30
Samsara BioCapital	6,897,652	$379.4M	2026-06-30
PRICE T ROWE ASSOCIATES	6,794,837	$373.7M	2026-06-30
WELLINGTON MANAGEMENT GROUP LLP	6,727,085	$370.0M	2026-06-30
Orbis Allan Gray Ltd	5,933,533	$326.3M	2026-06-30
VANGUARD CAPITAL MANAGEMENT	4,767,880	$262.2M	2026-06-30
STATE STREET	4,728,681	$260.1M	2026-06-30
Redmile Group	4,311,092	$237.1M	2026-06-30

SEC EDGAR: CIK 1727196 →

Scholar Rock Holding Corp

SRRK

NasdaqMid CapHealthcare

13F Pro Quality Score

Not in ranked universe

Pending next ranking run

This company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. Rankings refresh on Jan 1, Apr 1, Jul 1, Oct 1.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.